Risk modification in patients with peripheral arterial disease: a retrospective survey (Q46486524)

22 December 2017

title

Risk modification in patients with peripheral arterial disease: a retrospective survey (English)

1 reference

22 December 2017

author

Dimitri P Mikhailidis

series ordinal

3

object named as

Dimitri P Mikhailidis

1 reference

22 December 2017

Fahed Youssef

1

1 reference

22 December 2017

Prakash Gupta

series ordinal

2

1 reference

22 December 2017

George Hamilton

series ordinal

4

1 reference

22 December 2017

publication date

1 May 2005

1 reference

22 December 2017

published in

Angiology

1 reference

22 December 2017

volume

56

1 reference

22 December 2017

issue

3

1 reference

22 December 2017

page(s)

279-287

1 reference

22 December 2017

Management of intermittent claudication: the importance of secondary prevention

cites work

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

Factors affecting the diagnosis of peripheral vascular disease before vascular surgery referral

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

The significance of lower extremity peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

Femoral atherosclerosis in an older British population: prevalence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

PAD awareness, risk, and treatment: new resources for survival--the USA PARTNERS program

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

Second best medical therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

Peripheral arterial disease: medical care and prevention of complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

The role of tobacco cessation, antiplatelet and lipid-lowering therapies in the treatment of peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

Effects of exercise rehabilitation on cardiovascular risk factors in older patients with peripheral arterial occlusive disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

Treating patients with peripheral arterial disease and claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

Low-dose aspirin and subsequent peripheral arterial surgery in the Physicians' Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

Systematic review of antiplatelet therapy for the prevention of myocardial infarction, stroke or vascular death in patients with peripheral vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

Statin therapy improves cardiovascular outcome of patients with peripheral artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

Frequency of new coronary events in older persons with peripheral arterial disease and serum low-density lipoprotein cholesterol > or = 125 mg/dl treated with statins versus no lipid-lowering drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

The early effect of lipid-lowering treatment on carotid and femoral intima media thickness (IMT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

Effects of initial and long-term lipid-lowering therapy on vascular wall characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

Bezafibrate in men with lower extremity arterial disease: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

Intermittent claudication. A risk profile from The Framingham Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

Treatment of peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

Predictors of subsequent coronary events, stroke, and death among survivors of first hospitalized myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

Intermittent claudication in 8343 men and 21-year specific mortality follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

The relationship between ankle-arm index and mortality in older men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

Prevalence and correlates of symptomatic peripheral atherosclerosis in individuals with coronary heart disease and cholesterol levels less than 240 mg/dL: baseline results from the Cholesterol and Recurrent Events (CARE) Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

Missed opportunities to treat atherosclerosis in patients undergoing peripheral vascular interventions: insights from the University of Michigan Peripheral Vascular Disease Quality Improvement Initiative (PVD-QI2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

Role of fibrates in reducing coronary risk: a UK Consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

Statins and renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

The effect of short-term treatment with simvastatin on renal function in patients with peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

Treating peripheral arterial disease in patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

Smoking diminishes the beneficial effect of statins: observations from the landmark trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

Antiplatelet therapy in peripheral arterial disease. Consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

Thyroid disease and lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600307

10.1177/000331970505600307

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017